🏥 Health
Live
Study Links Higher GLP-1 Doses to Better Heart, Metabolic Results
A study shows higher GLP-1 doses yield better heart and metabolic results. This supports personalized dosing to maximize benefits and minimize side effects for diabetes and weight loss patients.
The Hill — 31 July 2026
Text:
25
0
0
GLP‑1 drugs could become personalized for individuals, study says. Researchers found that higher‑dose GLP‑1 agonists produced larger improvements in h
Read Full Story at The Hill → Sources
🏥 Health
Sudan war cuts subsidies, spikes cancer drug prices
🏥 Health
Oxford administers experimental Bundibugyo Ebola vaccine to first patient
🏥 Health
Ebola death toll in DR Congo surpasses 1,000
🏥 Health
UK humanitarian worker monitored for Ebola in London hospital
🏥 Health
Why the U.S. is losing the global sunscreen race
🏥 Health
African countries are facing rising rates of cancer. What's being done about it?
